Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil A Bhowmick

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Endocrine-Related Cancer|October 25, 2019
Soluble CD105 is prognostic of disease recurrence in prostate cancer patientsVeronica R Placencio-Hickok, Anisha Madhav, Sungjin Kim, et al.
Cancers|March 13, 2024
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the ConventionHayato Muranaka, Rasaq Akinsola, Sandrine Billet, et al.
Plos One|January 26, 2013
A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma modelsHao Zhang, Dror Berel, Yanping Wang, et al.
Anticancer Research|March 6, 2020
Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate CancerAdriana C Vidal, Frank Duong, Lauren E Howard, et al.
The American Journal of Pathology|December 5, 2009
Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closureMagaly Martinez-Ferrer, Ali-Reza Afshar-Sherif, Consolate Uwamariya, et al.
Breast Cancer Research : BCR|October 29, 2003
Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell lineLu Xie, Brian K Law, Mary E Aakre, et al.
Scientific Reports|December 21, 2016
Histone deacetylase inhibitors mediate DNA damage repair in ameliorating hemorrhagic cystitisSubhash Haldar, Christopher Dru, Rajeev Mishra, et al.
The Journal of Urology|September 9, 2005
Stromal hyperplasia in male bladders upon loss of transforming growth factor-beta signaling in fibroblastsAli-Reza Sharif-Afshar, Jeffrey M Donohoe, John C Pope, et al.
Cancers|November 25, 2023
ARID1A Deficiency Regulates Anti-Tumor Immune Response in Esophageal AdenocarcinomaLe Zhang, Yueyuan Zheng, Wenwen Chien, et al.
The Journal of Pathology|November 10, 2011
Loss of epithelial oestrogen receptor α inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout modelsMing Chen, Chiuan-Ren Yeh, Hong-Chiang Chang, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Endocrine-Related Cancer|October 25, 2019
Soluble CD105 is prognostic of disease recurrence in prostate cancer patientsVeronica R Placencio-Hickok, Anisha Madhav, Sungjin Kim, et al.
Cancers|March 13, 2024
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the ConventionHayato Muranaka, Rasaq Akinsola, Sandrine Billet, et al.
Plos One|January 26, 2013
A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma modelsHao Zhang, Dror Berel, Yanping Wang, et al.
Anticancer Research|March 6, 2020
Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate CancerAdriana C Vidal, Frank Duong, Lauren E Howard, et al.
The American Journal of Pathology|December 5, 2009
Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closureMagaly Martinez-Ferrer, Ali-Reza Afshar-Sherif, Consolate Uwamariya, et al.
Breast Cancer Research : BCR|October 29, 2003
Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell lineLu Xie, Brian K Law, Mary E Aakre, et al.
Scientific Reports|December 21, 2016
Histone deacetylase inhibitors mediate DNA damage repair in ameliorating hemorrhagic cystitisSubhash Haldar, Christopher Dru, Rajeev Mishra, et al.
The Journal of Urology|September 9, 2005
Stromal hyperplasia in male bladders upon loss of transforming growth factor-beta signaling in fibroblastsAli-Reza Sharif-Afshar, Jeffrey M Donohoe, John C Pope, et al.
Cancers|November 25, 2023
ARID1A Deficiency Regulates Anti-Tumor Immune Response in Esophageal AdenocarcinomaLe Zhang, Yueyuan Zheng, Wenwen Chien, et al.
The Journal of Pathology|November 10, 2011
Loss of epithelial oestrogen receptor α inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout modelsMing Chen, Chiuan-Ren Yeh, Hong-Chiang Chang, et al.
Pageof 11